Podcast Pearls
An Overview of AML and Treatment Strategies for Patients Unfit for Intensive Therapy

Download this PDF resource with summary points from a podcast episode featuring Ashley Leak Bryant, PhD, RN, OCN, FAAN, discussing acute myeloid leukemia and management approaches for patients unfit for intensive chemotherapy with a focus on the nursing perspective.
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Format: Adobe Acrobat (.pdf)
File Size: 546 KB
Released: January 6, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie

Information on this Educational Activity

Faculty

Ashley Leak Bryant, PhD, RN, OCN, FAAN

Associate Professor
School of Nursing
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Ashley Leak Bryant, PhD, RN, OCN, FAAN, has disclosed that she has received funds for research support from Jazz.

Program Medium

This program has been made available online.

Related Content

Expert text module that provides insights from a leading patient advocate/healthcare professional on best practices in education for patients with CLL, from Clinical Care Options (CCO)

Nichole Fisher Headshot Nichole Fisher, RN, BSN Brian Koffman, MDCM (retired), MS Ed Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 17, 2022 Expired: August 16, 2023

Comentario experto de los datos de la EHA 2022 sobre inhibidores de la QBT para LLC y LCM de Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Expertengespräch über die Daten der EHA 2022 zu BTK-Inhibitoren für CLL und MCL, von Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Comentários de especialistas sobre dados do EHA 2022 sobre os inibidores de BTK para LLC e LCM, do Clinical Care Options (CCO)

Othman Al-Sawaf, MD Lydia Scarfò, MD Released: August 15, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings